Why Cameco, Oklo, and NuScale Power Stocks All Popped Today

Nuclear stocks, including Oklo (OKLO), NuScale Power (SMR), and Cameco (CCJ), rose following President Trump's executive orders aimed at accelerating nuclear power development and Goldman Sachs' highlighting Cameco and NuScale as beneficiaries. Oklo also gained on a memorandum of understanding with Korea Hydro & Nuclear Power to advance its Aurora powerhouse development; however, analysts suggest Cameco is the most 'investable' in the space, despite a high price-to-free cash flow ratio, while remaining cautious about the overall profitability potential for investors in the nuclear industry at current valuations.

Analysis

The nuclear sector experienced a broad rally, with Oklo (OKLO) rising 2%, NuScale Power (SMR) 8.6%, and Cameco (CCJ) 5.8%, largely driven by newly signed executive orders aimed at accelerating U.S. nuclear power development and a Goldman Sachs note highlighting Cameco and NuScale as key beneficiaries. Oklo separately announced a memorandum of understanding with Korea Hydro & Nuclear Power to jointly advance its Aurora powerhouse, potentially leveraging Korea Hydro's $11 billion annual revenue for R&D support, though Oklo remains pre-revenue with zero current annual revenue and awaits license approval for its stated 14 gigawatt order pipeline. NuScale, while also pre-profit with less than $50 million in expected revenue this year and profitability not anticipated before 2030, benefits from being the first Small Modular Reactor (SMR) with a U.S. Nuclear Regulatory Commission (NRC)-certified design. Cameco, valued over $26 billion, presents as a more established entity with nearly $2.4 billion in annual revenue, $181 million in net income over the last twelve months, and $504 million in annual free cash flow, yet trades at a demanding price-to-free cash flow ratio exceeding 50. Despite these positive catalysts and distinct company profiles, the overarching sentiment derived from the article, supported by a mixed general sentiment score (-0.1) and cautious tone, questions the immediate profit potential for investors across the industry at current valuations due to the speculative nature of emerging technologies and high multiples for established players.

Key Decisions for Investors

• Exercise caution with pre-revenue SMR developers like Oklo and NuScale, recognizing the speculative nature and long timeline to commercialization and profitability, despite positive regulatory signals and individual company milestones like NuScale's NRC certification.
• For Cameco, acknowledge its established, profitable operations and significant free cash flow, but critically assess if its current price-to-free cash flow ratio above 50 is justified by future growth prospects in an expanding nuclear market.
• Monitor key inflection points such as progress on NRC Combined License Applications (COLA) for SMR developers and evolving uranium market dynamics, as these will be critical for validating investment theses in the sector.
• Given the prevailing high valuations and uncertain profitability across parts of the nuclear industry, investors should adopt a highly selective approach or consider the speculative nature of these investments within a well-diversified portfolio.